Cancer remains one of the ultimate frontiers of modern science and medicine. To defeat an enemy this adaptive, we must first decipher its language. Understanding Cancer Biology is a definitive, panoramic guide meticulously crafted for students, researchers, and healthcare professionals seeking to comprehend the chaotic inner workings of malignant neoplasia. This textbook bridges the gap between raw molecular data and clinical applications, transforming an overwhelmingly complex disease into a structured, comprehensible narrative of biological survival. Far from a dry recitation of clinical stats, this book treats cancer as a dynamic, evolving ecosystem. It maps the terrifying trajectory of normal human cells as they subvert homeostasis, ignore replication checkpoints, and wage a multi-front rebellion against the host body. By exploring cancer at every tier of organization—from macroscopic pathology down to genetic mutations and cell-signaling pathways—this text delivers the foundational clarity required to drive the next generation of oncology breakthroughs. The book unfoldsmeticulously designed sections, guiding the reader from fundamental cellular physics to the cutting-edge frontiers of post-genomic medicine. Demystifies the fragile balance of normal cell division and homeostasis, pinpointing the exact triggers that cause a healthy cell to cross the threshold into malignant transformation. An in-depth exploration of the cell cycle checkpoints, tumor suppressors, and growth-regulatory genes. It breaks down how subtle errors in genetics and cancer epigenetics dismantle cellular regulation. Examines the mechanisms of chemical, environmental, physical, and viral carcinogens that damage cellular architecture and jumpstart the mutation engine. Illustrates how tumors do not act alone. Learn how cancer cells manipulate their surrounding microenvironment, trigger angiogenesis to feed themselves, and breach biological barriers to colonize distant organs via metastasis. Journeys into modern oncological arsenals. Discover how molecular profiling, proteomics, metabolomics, and systems biology are giving rise to ultra-precise diagnostics and custom-tailored targeted treatments. The Dark Horse of Oncology: A forward-looking evaluation of the human microbiome’s role in cancer progression and its untapped potential to alter therapeutic outcomes.
Hanahan D. Coussens is a world-renowned molecular biologist, oncologist, and leading authority in translational cancer research, currently serving as a Distinguished Professor of Oncology and Director of the Integrated Cancer Biology Program at a premier biomedical research institution. With over twenty-five years of pioneering research at the intersection of cellular genetics and the tumor microenvironment, Dr. Coussens has dedicated his career to dismantling the complex mechanisms that govern tumor progression, metastasis, and therapeutic resistance. Dr. Coussens earned his Ph.D. in Molecular and Cellular Biology from Harvard University, where his early work on oncogenic signaling pathways laid foundational groundwork for modern targeted therapies. He later completed his postdoctoral fellowship at the Cold Spring Harbor Laboratory, collaborating with Nobel laureates to map the intricate communication networks between cancer cells and the host immune system. His academic journey began with a Bachelor of Science in Biochemistry with Highest Honors from the University of California, Berkeley. Over the course of his distinguished career, Dr. Coussens has authored more than 150 peer-reviewed studies published in leading scientific journals, including Nature, Science, and Cell. His seminal research on how chronic inflammation fuels neoplastic progression has fundamentally shifted the paradigm of oncology, earning him the prestigious (IACR) Outstanding Achievement Award and election to the National Academy of Sciences. Beyond the laboratory, he serves as a senior editorial board member for multiple high-impact oncology journals and acts as a primary consultant for global biotechnology firms developing next-generation immunotherapies.
Preface CHAPTER 1: THE MULTICELLULAR ORGANISM AND CANCER Introduction A Brief History Of The Cell: Eubacteria (Bacteria), Archaea, Eukaryotes, And The Last Unknown Common Ancestors Basic Anatomy Of The Eukaryotic Cell In Metazoa The Life Of The Single Cell Multicellular Organisms And The Development Of Cancer Cancer As A Disease Of The Multicellular Organism Conclusion CHAPTER 2: DNA REPAIR AND GENOME INTEGRITY Introduction Molecular Aspects Of The DNA Damage Response The DNA Damage Response Activity During Normal Cell Physiology Defect In DNA Damage Response And Cancer DNA Damage Response Pathway Components As Targets For Chemo- And Radio-Sensitization CHAPTER 3: HOW CANCERS SPREAD Introduction Tumor Angiogenesis Invasion And Metastasis Summary CHAPTER 4: IDENTIFYING THE CAUSES OF CANCER Introduction The Epidemiological Approach The Experimental Approach The Main Causes Of Human Cancer Summary CHAPTER 5: CHEMICALS AND CANCER Introduction Identifying Chemicals That Cause Cancer Mechanisms Of Chemical Carcinogenesis Summary CHAPTER 6: RADIATION AND CANCER Introduction Sunlight And Ultraviolet Radiation Ionizing Radiation Other Forms Of Radiation Summary CHAPTER 7: HEREDITY AND CANCER Introduction Hereditary Risk: Genes Involved In Restraining Cell Proliferation Hereditary Risk: Genes Affecting DNA Repair And Genetic Stability Hereditary Risk: Other Genes And Issues Summary CHAPTER 8: INFECTIOUS AGENTS AND CANCER Introduction Infectious Agents In Human Cancers How Infections Cause Cancer Summary CHAPTER 9: ONCOGENES Introduction How Cellular Oncogenes Arise Proteins Produced By Oncogenes Summary CHAPTER 10: TUMOR SUPPRESSOR GENES AND CANCER OVERVIEW Introduction Tumor Suppressor Genes: Roles In Cell Proliferation And Cell Death Tumor Suppressor Genes: Roles In DNA Repair And Genetic Stability Overview Of Carcinogenesis Summary CHAPTER 11: CANCER SCREENING, DIAGNOSIS, AND TREATMENT Introduction Cancer Screening And Diagnosis Surgery, Radiation, And Chemotherapy Emerging Treatments: Immunotherapy And Molecular Targeting Clinical Trials And Other Approaches Summary BIBLIOGRAPHY INDEX
$280.00